Matches in Wikidata for { <http://www.wikidata.org/entity/Q65371622> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65371622 description "clinical trial" @default.
- Q65371622 description "ensayu clínicu" @default.
- Q65371622 description "klinisch onderzoek" @default.
- Q65371622 description "клінічне випробування" @default.
- Q65371622 name "Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers" @default.
- Q65371622 name "Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers" @default.
- Q65371622 type Item @default.
- Q65371622 label "Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers" @default.
- Q65371622 label "Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers" @default.
- Q65371622 prefLabel "Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers" @default.
- Q65371622 prefLabel "Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers" @default.
- Q65371622 P1050 Q65371622-04DDDF58-31B0-48A5-B7DA-A0782AA8E13E @default.
- Q65371622 P1132 Q65371622-44ABC55C-156C-4800-95BA-5C75435BD313 @default.
- Q65371622 P1476 Q65371622-257F0944-E65B-4C45-BA31-B5FC977B7475 @default.
- Q65371622 P17 Q65371622-C962256C-03D8-4A89-B119-EC5509A84CA4 @default.
- Q65371622 P2899 Q65371622-1BD285F9-773A-4233-9739-04BC6A551C88 @default.
- Q65371622 P3098 Q65371622-46603D6D-F79A-46B4-9838-9D9FE41D7A3E @default.
- Q65371622 P31 Q65371622-CFAD6D31-90D9-48E0-AE3A-23C34C581668 @default.
- Q65371622 P4135 Q65371622-26C0E534-ED91-446A-B205-8C3EBAC3738A @default.
- Q65371622 P580 Q65371622-AA91E247-67D7-4F01-B2C9-268D4749D8A3 @default.
- Q65371622 P582 Q65371622-D35B1F0F-61A4-48EE-9552-FDEECC203E94 @default.
- Q65371622 P6099 Q65371622-E4D7C600-8B79-4C1B-B690-F9ED6C289FFF @default.
- Q65371622 P8363 Q65371622-AFB001D2-4F4C-4128-AF7B-A4B4E32C5D22 @default.
- Q65371622 P1050 Q12204 @default.
- Q65371622 P1132 "+74" @default.
- Q65371622 P1476 "Phase I, Double-Blind, Randomized, Single-Center, Five-Period Crossover Study to Assess the Effects of Single Oral Doses of 400 mg and 1000 mg of PA-824 and 400 mg of PA-824 Plus 400 mg of Moxifloxacin on QTc Interval Compared to Placebo, Using AVELOX™ (Moxifloxacin) as a Positive Control, in Healthy Male and Female Volunteers Aged 18 to 45 Years" @default.
- Q65371622 P17 Q30 @default.
- Q65371622 P2899 "+18" @default.
- Q65371622 P3098 "NCT01674218" @default.
- Q65371622 P31 Q30612 @default.
- Q65371622 P4135 "+45" @default.
- Q65371622 P580 "2012-09-01T00:00:00Z" @default.
- Q65371622 P582 "2012-12-01T00:00:00Z" @default.
- Q65371622 P6099 Q5452194 @default.
- Q65371622 P8363 Q78089383 @default.